Clinical Trial Update: NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab in stratified treatment for colon cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University College, London | Conditions: Adenocarcinoma of the Colon | Phase 2 | Status: RECRUITING